TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from OptiBiotix Health ( (GB:OPTI) ) is now available.
OptiBiotix Health plc announced that its Chief Executive, Stephen O’Hara, has purchased additional ordinary shares in the company, increasing his stake to 10.08%. This transaction, disclosed under UK Market Abuse Regulation, signifies confidence in the company’s strategic direction and may positively influence investor sentiment.
More about OptiBiotix Health
OptiBiotix Health plc is a life sciences company focused on developing products that enhance the gut microbiome, reduce hunger and food cravings, and provide healthy sugar substitutes. The company collaborates with over twenty international food and healthcare supplement companies to incorporate its microbiome modulators into various food and drink products. OptiBiotix also develops its own range of consumer health products, targeting areas such as obesity, cardiovascular health, and diabetes.
Average Trading Volume: 215,936
Technical Sentiment Signal: Sell
Current Market Cap: £10.02M
Find detailed analytics on OPTI stock on TipRanks’ Stock Analysis page.